Deoxyribonucleic acid (DNA) N7-guanine (N7-G)

DNA strands at the N7 position of guanine are the primary molecular targets for alkylating chemotherapy agents, which are among the oldest and most widely used classes of anticancer drugs (StatPearls, 2023). The N7 atom of guanine is the most nucleophilic site in the DNA double helix, making it highly reactive toward electrophilic alkylating species generated by drugs like cyclophosphamide, melphalan, and temozolomide (National Cancer Institute). Upon reaction, these drugs form covalent adducts that can result in DNA cross-linking—either between two strands (interstrand) or within a single strand (intrastrand)—effectively blocking the machinery required for DNA replication and RNA transcription (PubMed, PMID: 15151910). Furthermore, alkylation at the N7 position can destabilize the glycosidic bond, leading to depurination and subsequent DNA strand breakage (ACS Chemical Biology). These cumulative DNA lesions trigger cell cycle arrest and apoptosis, particularly in rapidly proliferating malignant cells. However, because these agents are not specific to cancer cells, they often cause significant toxicities, including myelosuppression and an increased risk of therapy-related secondary malignancies (American Cancer Society).

Other names

Guanine N7 positionN7-alkylguanineDNA guanine N7N7-methylguanine site

Covalent DNA alkylation, DNA cross-linking, induction of DNA strand breaks, and inhibition of DNA replication and transcription (StatPearls, 2023).